Study Evaluating Efficacy and Safety of Froniglutide (PF1801) in Patients With Idiopathic Inflammatory Myopathy

NCT05833711 · clinicaltrials.gov ↗

PHASE2

Phase

UNKNOWN

Status

39

Enrollment

INDUSTRY

Sponsor class

Conditions

Dermatomyositis
Polymyositis
Idiopathic Inflammatory Myopathies

Interventions

DRUG: Froniglutide
DRUG: Placebo

Sponsor

Immunoforge Co. Ltd.